Apellis Pharmaceuticals, Inc. (APLS)
20.14
+0.28
(+1.41%)
USD |
NASDAQ |
Mar 05, 16:00
20.14
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Free Cash Flow : 45.01M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ultragenyx Pharmaceutical, Inc. | -487.00M |
| Amneal Pharmaceuticals, Inc. | 225.64M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| Amicus Therapeutics, Inc. | 29.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.18M |
| Cash from Investing (Quarterly) | -0.108M |
| Cash from Financing (Quarterly) | 1.259M |
| Free Cash Flow Per Share (Quarterly) | -0.1128 |
| Free Cash Flow to Equity (Quarterly) | -13.27M |
| Free Cash Flow to Firm (Quarterly) | -3.379M |
| Free Cash Flow Yield | 1.76% |